Latest News & Features
Refine Search
Americas
A new charter aims to help decarbonise IP operations and contribute to the energy transition. Its founders—Fabrice Mattei of Rouse, and Simone Frattasi of Maersk—tell Sarah Speight how. 12 August 2025
Americas
A patent fee structure being mooted in the US could hurt the innovation economy, especially in industries like biotech and pharma—and will face backlash from businesses, writes Paul Hunter of Foley. 12 August 2025
Americas
Administration targets university’s federally funded research | Commerce Secretary warns of patent seizure under Bayh-Dole Act | Harvard given deadline to provide list of federally funded patents | Uncertainty continues across universities amid broader research cuts. 11 August 2025
Careers
The trio bring experience in patent, trade secret, and commercial disputes across high tech, biotech, and life sciences, with two returning to Weil after more than a decade. 11 August 2025
Americas
Payout and licensing deal grants US rights to COVID-19 and flu products | Agreement paves way for BioNTech’s $1.25 billion acquisition of CureVac. 8 August 2025
Europe
Captisol dispute intensifies as Italian court sides with Bexson | CyDex claims of trade secret misuse dismissed in early-stage ruling | Case relates to ongoing US dispute. 7 August 2025
Big Pharma
With AI accelerating drug development, pharma companies must rethink how they protect models, data, and innovation, say Camille Terfve and Sean Jauss of Mewburn Ellis. 6 August 2025
Careers
A litigator, who led the Unified Patent Court group at his previous firm, brings experience spanning the physics, software, and medical device sectors. 6 August 2025
Europe
A much-anticipated referral could upend the EPO’s controversial description amendment rule—and reshape European patent practice, as the Enlarged Board of Appeal prepares to weigh in on G 1/25. 5 August 2025
Europe
UK Court of Appeal upholds key Moderna patent against Pfizer and BioNTech | Comirnaty vaccine ruled to infringe European mRNA technology patent. 4 August 2025